# False-Positive Detection of Haemophilus influenzae by a Multiplex PCR Panel in a Neonate With Late-Onset Group B Streptococcal Bacteremia

**Authors:** Koji Yokoyama, Ayako Okamoto, Misako Ohkusu, Naruhiko Ishiwada

PMC · DOI: 10.7759/cureus.86997 · Cureus · 2025-06-29

## TL;DR

A neonate with Group B Streptococcal bacteremia was falsely diagnosed with Haemophilus influenzae using a multiplex PCR panel, highlighting the need for confirmatory testing and improved diagnostic clarity.

## Contribution

This case highlights a diagnostic limitation of multiplex PCR panels and advocates for better algorithmic transparency and validation.

## Key findings

- A neonate's CSF tested falsely positive for Haemophilus influenzae using the FilmArray ME panel.
- Confirmatory PCR and culture testing showed no evidence of H. influenzae or meningitis.
- The false positive was due to borderline amplification of one H. influenzae target interpreted as positive.

## Abstract

Here, we report the case of a term neonate with late-onset Group B Streptococcal (GBS) bacteremia in whom the FilmArray® Meningitis/Encephalitis (ME) panel (BioFire Diagnostics, Salt Lake City, UT, US) falsely detected Haemophilus influenzae in the cerebrospinal fluid (CSF). Although the CSF showed mild pleocytosis and elevated protein, there were no clinical signs of bacterial meningitis. Confirmatory testing, including multiplex PCR targeting H. influenzae (siaT), GBS (cfb), and 16S rRNA, as well as CSF culture, yielded negative results. Repeat FilmArray testing under controlled conditions was also negative. A manufacturer's investigation revealed borderline amplification of only one of the H. influenzae targets, which was interpreted algorithmically as positive. This discordance highlights a key limitation of multiplex PCR panels: the lack of transparency in signal interpretation and threshold settings. The patient demonstrated no immunodeficiency and remained clinically stable during a 10-month follow-up. This case underscores the importance of confirmatory testing when panel results contradict the clinical picture and advocates for improved algorithmic clarity and inter-laboratory validation. Increased awareness of such diagnostic pitfalls is essential, particularly in neonatal settings where unnecessary antimicrobial interventions may pose additional risks.

## Linked entities

- **Diseases:** bacterial meningitis (MONDO:0006670)
- **Species:** Haemophilus influenzae (taxon 727)

## Full-text entities

- **Diseases:** lethargy (MESH:D053609), GBS bacteremia (MESH:D013290), central nervous system infections (MESH:D002494), sepsis (MESH:D018805), Late-Onset Group B (MESH:D003057), fever (MESH:D005334), Encephalitis (MESH:D004660), pleocytosis (MESH:D007964), Immunodeficiency (MESH:D007153), Meningitis (MESH:D008580), bacterial meningitis (MESH:D016920)
- **Chemicals:** CTX (-), cefotaxime (MESH:D002439), ABPC (MESH:D000667), glucose (MESH:D005947)
- **Species:** Haemophilus influenzae (species) [taxon 727], Streptococcus sp. 'group B' (species) [taxon 1319], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310403/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12310403/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310403/full.md

---
Source: https://tomesphere.com/paper/PMC12310403